公开(公告)号：US20240148971A1

公开(公告)日：2024-05-09

申请号：US18386647

申请日：2023-11-03

Applicant: INSULET CORPORATION

Inventor： Matthew ALLES ,  Yibin ZHENG ,  Joon Bok LEE ,  James CAUSEY ,  Jason O'CONNOR

IPC: A61M5/172 ,  A61M5/142

CPC classification number: A61M5/1723 ,  A61M5/14248 ,  A61M2202/0486

Abstract: Exemplary embodiments may provide an on-body medicament delivery system that provides basal delivery of a medicament to a type 2 diabetes patient and that automatically performs medicament titration for the patient. The medicament delivery system performs medicament titration based on glucose level readings for the patient. These glucose levels may be provided wirelessly from a glucose sensor, such as a continuous glucose monitor, or may be entered manually by the patient into a management device, such as a smartphone running an application that provides a user interface for the patient to enter the glucose level readings. The medicament delivery system adjusts the basal medicament delivery rate/dose based on the glucose level readings for the patient. The adjustments may be performed by a programmatic mechanism, such as by computer programming instructions executing on a processor.

公开(公告)号：US20220193337A1

公开(公告)日：2022-06-23

申请号：US17554514

申请日：2021-12-17

Applicant: Insulet Corporation

Inventor： Matthew ALLES ,  Joon Bok LEE

IPC: A61M5/172 ,  G04G9/00

Abstract: The exemplary embodiments may provide a smartwatch or a vehicle infotainment system with management and data inspection capabilities for a medicament delivery system. A user may view medicament delivery history and analyte level history via the smartwatch or auto mobile infotainment system. In addition, a user may calculate a medicament dosage and prompt delivery of the medicament bolus dosage via the smartwatch or vehicle infotainment system. Notifications also may be delivered to the user via the smartwatch and vehicle infotainment system.

公开(公告)号：US20230011699A1

公开(公告)日：2023-01-12

申请号：US17860609

申请日：2022-07-08

Applicant: INSULET CORPORATION

Inventor： Joon Bok LEE ,  Matthew ALLES ,  Yibin ZHENG ,  Jason O'CONNOR

IPC: A61M5/172

Abstract: Provided are techniques, devices and systems that include monitoring a trend of blood glucose measurement values over a series of measurement cycles. A processor may identify a potential excursion outside a range of a target blood glucose measurement value setting of a user based on the monitored trend. In response to the identified potential excursion, an alert may be generated to the user to consume rescue carbohydrates. In addition, the disclosed techniques may include a processor that assesses the factors related to a potential impending hypoglycemic event for a user. Based on a result of the assessment of the factors, the processor may determine whether the user is approaching the potential impending hypoglycemic event for the user. In response to a determination that the user is approaching the potential impending hypoglycemic event for the user, a number of rescue carbohydrates to suggest for consumption by the user may be determined.

公开(公告)号：US20220062536A1

公开(公告)日：2022-03-03

申请号：US17412729

申请日：2021-08-26

Applicant: Insulet Corporation

Inventor： Jason O'CONNOR ,  Matthew ALLES ,  Robert SANZONE ,  Craig BRODEUR ,  Joseph MELO ,  Christopher WILLIAMS ,  Noel SCHAEFFER

IPC: A61M5/142

Abstract: The disclosed embodiments are directed to a wearable automatic drug delivery device configured to provide basal-only dosing of insulin. In a primary embodiment, the wearable drug delivery device is configured to provide automatic operation and provides audible alerts and visual status indicators to the patient. In other embodiments, the patient may have some degree of control over the operation of the device by providing tapping gestures on housing of the device. In yet another embodiment, the patient may provide input and receive status from the device via an application executing on a portable computing device in wireless communication with the wearable drug delivery device.

公开(公告)号：US20250065039A1

公开(公告)日：2025-02-27

申请号：US18885257

申请日：2024-09-13

Applicant: INSULET CORPORATION

Inventor： Jason O'CONNOR ,  Matthew ALLES ,  Robert SANZONE ,  Craig BRODEUR ,  Joseph MELO ,  Christopher WILLIAMS ,  Noel SCHAEFFER

IPC: A61M5/142

Abstract: The disclosed embodiments are directed to a wearable automatic drug delivery device configured to provide basal-only dosing of insulin. In a primary embodiment, the wearable drug delivery device is configured to provide automatic operation and provides audible alerts and visual status indicators to the patient. In other embodiments, the patient may have some degree of control over the operation of the device by providing tapping gestures on housing of the device. In yet another embodiment, the patient may provide input and receive status from the device via an application executing on a portable computing device in wireless communication with the wearable drug delivery device.

公开(公告)号：US20220199215A1

公开(公告)日：2022-06-23

申请号：US17555040

申请日：2021-12-17

Applicant: Insulet Corporation

Inventor： Matthew ALLES ,  Daniel MURRAY ,  Joon Bok LEE ,  Jason O'CONNOR

IPC: G16H20/13 ,  G08B21/24 ,  G08B25/00 ,  G08B5/22 ,  G06F3/04842

Abstract: Exemplary embodiments may enable a user to schedule medicament bolus deliveries, such as insulin boluses, for future dates and times. The exemplary embodiments may provide the ability to delay a scheduled medicament bolus delivery by short periods of time. The user may reschedule a scheduled medicament bolus delivery by entering a new date and/or time for the medicament bolus delivery. Still further, a user may cancel a scheduled medicament bolus delivery. In addition, exemplary embodiments may enable multiple medicament bolus deliveries to be viewed and managed.